Menu
Back to Journals » International Journal of Nanomedicine » Volume 15
RETRACTED ARTICLE: Stimulus Responsive Ocular Gentamycin-Ferrying Chitosan Nanoparticles Hydrogel: Formulation Optimization, Ocular Safety and Antibacterial Assessment
Authors Alruwaili NK, Zafar A, Imam SS , Alharbi KS , Alotaibi NH, Alshehri S , Alhakamy NA , Alzarea AI , Afzal M, Elmowafy M
Received 22 March 2020
Accepted for publication 8 May 2020
Published 30 June 2020 Volume 2020:15 Pages 4717—4737
DOI https://doi.org/10.2147/IJN.S254763
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
Editor who approved publication: Dr Thomas Webster
This paper has been retracted.
Alruwaili NK, Zafar A, Imam SS, et al. Int J Nanomedicine. 2020;15:4717–4737.
The Editor and Publisher of International Journal of Nanomedicine wish to retract the published article. Concerns were raised regarding the alleged duplication of isotonicity images in Figure 8. The corresponding author did cooperate with the investigation and images relating to the isontonicity study were provided. However, despite the authors’ assistance, it was still not clear how the images came to be duplicated, and, as we cannot verify the validity of the published work, we are therefore retracting the article. The authors have been informed and do not agree with this decision.
We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.